Speech-Language Pathologists in Kentucky - Medicare Status, Address, Contact

2688 Speech-Language Pathologists found. Showing 61 - 80

Sarah K Riggs, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 704 Bloomfield Rd, Bardstown, KY 40004 Phone: 502-331-5478    Fax: 502-348-9825

Anna Reynolds Green Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5804 Loretto Rd, Bardstown, KY 40004 Phone: 502-827-3572

Peggy A. Schlesinger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Welch Ln, Bardstown, KY 40004 Phone: 502-836-4414

Talk To Me Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 178 Marvin Downs Rd, Bardstown, KY 40004 Phone: 502-460-5677

Emily Board Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 106 Highland Dr, Bardstown, KY 40004 Phone: 502-294-0078

Michelle Hill Boren, M.S.CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 105 Heritage Park Way, Bardstown, KY 40004 Phone: 502-819-1391    Fax: 502-348-1789

Ms. Jennifer Spalding Hagan, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 222 Hollywood Dr, Bardstown, KY 40004 Phone: 502-507-1052

Anna L Riley, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1238 Old Nazareth Rd, Bardstown, KY 40004 Phone: 502-348-8511

Nicole Riney, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 S Salem Dr, Bardstown, KY 40004 Phone: 502-331-5478    Fax: 502-385-0234

Samantha Lynch, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 202 W Stephen Foster Ave Ste A, Bardstown, KY 40004 Phone: 502-233-1305

Patricia Hall, MS, CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 310 South 6th Street, Bardstown, KY 40004 Phone: 502-550-3534

Mrs. Jennifer Shrewsbury, M.S. SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 141 Limestone Blvd, Bardstown, KY 40004 Phone: 502-507-5076

Stephanie Wimpsett James, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Woodhill Rd, Bardstown, KY 40004 Phone: 502-424-0048

Julia Rogers Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 Manor Ave Ste 204, Bardstown, KY 40004 Phone: 502-233-1305

Ms. Amy Mudd Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 266 Guinan Way, Bardstown, KY 40004 Phone: 502-507-3233

Lauren Foster, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 47 Margo Ave, Bardwell, KY 42023 Phone: 270-628-5424

Holly Allen, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2529 Hazelwood Rd, Barlow, KY 42024 Phone: 270-559-3474

Mrs. Rebecca Singleton Goss, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1148 Coldiron Heights, Baxter, KY 40806 Phone: 606-573-6052    Fax: 606-573-4030

Mrs. Margaret Miracle, MA, CCC-SLP, AVT Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1148 Coldiron Heights, Baxter, KY 40831 Phone: 606-573-6052    Fax: 606-573-4030

Rachel Cornett Rose, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 162 Highway 522, Baxter, KY 40806 Phone: 606-574-0123    Fax: 606-574-0198

News Archive

Researchers find genetic proof on how osteoarthritis destroys cartilage

A team of orthopaedic researchers has found definitive, genetic proof of how the most common form of arthritis destroys joint cartilage in nearly 21 million aging Americans, according to a study published online Sept. 2 in the Journal of Bone and Mineral Research. The findings serve as an important foundation for the design of new treatments for osteoarthritis (OA), researchers said.

Low-income groups slow to seek treatment for stroke

People with lower incomes are less likely to present at a hospital within 3 hours of stroke symptoms and thus have lower rates of thrombolysis therapy or post-stroke care than their more affluent counterparts, according to a retrospective analysis.

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.

Positive top-line results from Idera's IMO-3100 Phase 2a trial on plaque psoriasis

Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.

Type 2 diabetes and cardiovascular disease share common risk factors

Type 2 diabetes (T2D) and cardiovascular disease (CVD) appear to have a lot in common. They share risk factors such as obesity and they often occur together. If they also share the same genetic underpinings, then doctors could devise a way to treat them together too.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »